Stock Research for CEMI

CEMI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CEMI Stock Chart & Research Data

The CEMI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CEMI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CEMI Due diligence Resources & Stock Charts

The CEMI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CEMI Detailed Price Forecast - CNN Money CNN View CEMI Detailed Summary - Google Finance
Yahoo View CEMI Detailed Summary - Yahoo! Finance Zacks View CEMI Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View CEMI Trends & Analysis - Trade-Ideas Barrons View CEMI Major Holders - Barrons
NASDAQ View CEMI Call Transcripts - NASDAQ Seeking View CEMI Breaking News & Analysis - Seeking Alpha
Spotlight View CEMI Annual Report - CompanySpotlight.com OTC Report View CEMI OTC Short Report - OTCShortReport.com
TradeKing View CEMI Fundamentals - TradeKing Charts View CEMI SEC Filings - Bar Chart
WSJ View Historical Prices for CEMI - The WSJ Morningstar View Performance/Total Return for CEMI - Morningstar
MarketWatch View the Analyst Estimates for CEMI - MarketWatch CNBC View the Earnings History for CEMI - CNBC
StockMarketWatch View the CEMI Earnings - StockMarketWatch MacroAxis View CEMI Buy or Sell Recommendations - MacroAxis
Bullish View the CEMI Bullish Patterns - American Bulls Short Pains View CEMI Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View CEMI Stock Mentions - StockTwits PennyStocks View CEMI Stock Mentions - PennyStockTweets
Twitter View CEMI Stock Mentions - Twitter Invest Hub View CEMI Investment Forum News - Investor Hub
Yahoo View CEMI Stock Mentions - Yahoo! Message Board Seeking Alpha View CEMI Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for CEMI - SECform4.com Insider Cow View Insider Transactions for CEMI - Insider Cow
CNBC View CEMI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CEMI - OTC Markets
Yahoo View Insider Transactions for CEMI - Yahoo! Finance NASDAQ View Institutional Holdings for CEMI - NASDAQ


Stock Charts

FinViz View CEMI Stock Insight & Charts - FinViz.com StockCharts View CEMI Investment Charts - StockCharts.com
BarChart View CEMI Stock Overview & Charts - BarChart Trading View View CEMI User Generated Charts - Trading View




Latest Financial News for CEMI


Chembio Diagnostics Announces Agreement with Bio-Manguinhos to Commercialize Point-of-Care Tests for Dengue, Zika and Chikungunya in Brazil
Posted on Thursday May 24, 2018

Chembio Diagnostics, Inc. (CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today announced the signing of a long-term agreement with Bio-Manguinhos to commercialize Chembio's POC diagnostic tests for Dengue, Zika and Chikungunya in Brazil. Bio-Manguinhos is a unit of the Oswaldo Cruz Foundation, a government agency responsible for the development and production of vaccines, diagnostics and biopharmaceuticals, primarily to meet the demands of Brazil's national public health system. Over the last 14 years, Chembio and Bio-Manguinhos have successfully collaborated to develop and commercialize a number of POC diagnostics, including tests for HIV, Syphilis, and Leishmania.


Chembio Diagnostics and Massachusetts General Hospital Enter Memorandum Of Understanding to Develop Point-of-Care Fever Diagnostic Test
Posted on Tuesday May 22, 2018

Under terms of the MOU, the parties would plan to combine Chembio’s patented DPP® technology with certain markers, which have been developed by researchers at MGH through the use of high-throughput immunoproteomic technologies, to develop POC diagnostic tests for Typhoid and febrile illness. The Chembio DPP® technology has been successfully used to develop sensitive and specific tests for POC infectious diseases which have been commercialized globally, including resource-limited areas.


Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors
Posted on Wednesday May 16, 2018

Dr. Potthoff has 25 years of experience in the clinical research services industry, with deep ties to diagnostics and pharmaceutical companies. Prior to Elligo, Dr. Potthoff was the CEO of Theorem Clinical Research, where he led the company through a period of significant growth and its acquisition by Chiltern International.


Edited Transcript of CEMI earnings conference call or presentation 9-May-18 8:30pm GMT
Posted on Monday May 14, 2018

Q1 2018 Chembio Diagnostics Inc Earnings Call


Stock Market & Investing Books

Enter a stock symbol to view the stock details.